Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Anna Maria Vandone"'
Autor:
Ornella Garrone, Massimo Di Maio, Claudia de Angelis, Andrea Michelotti, Matteo Paccagnella, Filippo Montemurro, Anna Maria Vandone, Andrea Abbona, Elena Geuna, Paola Vanella, Cristiana Lo Nigro, Antonella Falletta, Nicola Crosetto, Marco Merlano
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Anticancer drugs can interact with the tumour microenvironment and their effects could be exploited to favour anticancer immune response. Eribulin contributes to tumour vasculature remodelling and transforming growth factor β (TGF-β) mod
Externí odkaz:
https://doaj.org/article/93bef614d1984f27a29a9123b66b2e36
Autor:
Nerina Denaro, Cristina Granetto, Ornella Garrone, Vincenzo Ricci, Paola Vanella, Ida Colantonio, Nicola Crosetto, Anna Maria Vandone, Marcella Occelli, Fiorella Ruatta, Marco Merlano, Carolina Cauchi, Gianna Di Costanzo, Elena Fea
Publikováno v:
Tumori Journal. 106:427-431
Background:The coronavirus disease 2019 (COVID-19) pandemic is posing an unprecedented dilemma to oncologists worldwide, forcing them to decide whether to continue or suspend treatments in order to protect their most vulnerable patients from infectio
Autor:
Veronica Prati, anna maria vandone, Cinzia Ortega, Manuela Alessio, Morena Ciceri, giorgia zucchini
Publikováno v:
Qeios.
Background: the novel Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) was identified in 2019 inWuhan, China, and has not been previously identified in humans. SARS-CoV-2 disease resulted in a global pandemic, impacted on public health serv
Publikováno v:
Anti-Cancer Drugs. 30:543-553
The prognosis of metastatic melanoma has not changed throughout the 20th century. However, in the last decade, we have witnessed a continuous improvement in survival, with many long-term survivors. These results are largely because of the simultaneou
Autor:
Chiara Saggia, Andrea Milani, Marina Elena Cazzaniga, Maria Concetta Cursano, Eva Blondeaux, Anna Maria Vandone, Ornella Garrone, Alessandra Beano, Luigi Coltelli, N LaVerde, Marco Merlano, Antonio Nuzzo, Tommaso Giarratano, E. de Conciliis, Valentina Guarneri, Francesca Riva, Michela Donadio, L. Del Mastro, I. Bertolini, Andrea Michelotti, Mario Airoldi, Elena Collovà, Loretta D'Onofrio
Publikováno v:
Cancer Research. 78:P5-21
Background: Around 20% of breast cancers (BC) are HER-2+. Trastuzumab (T) has dramatically changed the outcome of HER-2+ BC patients (pts), both in early and in advanced settings. The combination of Pertuzumab (P) plus T and docetaxel, used as first-
Autor:
Marco Merlano, Paola Vanella, Daniele Lingua, Ornella Garrone, Emanuela Miraglio, Anna Maria Vandone
Publikováno v:
Future Oncology. 13:2759-2769
Eribulin is a synthetic analog of halichondrin B belonging to microtubule-targeted agents with a distinct mechanism of inhibition of microtubule dynamics. This molecule has multiple nonmitotic effects on tumor biology, exhibiting effects on epithelia
Autor:
Andrea Abbona, Nerina Denaro, Antonella Falletta, Paola Vanella, Daniela Rubini, Nicoletta Croce, Marco Merlano, Antonio Votero Prina, Anna Maria Vandone, Fiorella Ruatta, Ornella Garrone, Matteo Paccagnella
Publikováno v:
Journal of Clinical Oncology. 39:581-581
581 Background: The link between physical activity (PA) and the immune system (IS) is known. However, it is not yet fully understood the immune mechanisms activated by PA. We investigated the immune effect of moderate PA (MPA), nordic or fit walking,
Autor:
A. Farnesi, Eva Blondeaux, Filippo Montemurro, E. DeConciliis, Alessandra Beano, Ornella Garrone, Luigi Coltelli, L. Merlini, Elena Collovà, Livio Blasi, N. La Verde, A. Michelotti, Marco Merlano, Marina Elena Cazzaniga, Raffaele Ardito, Anna Maria Vandone, Tommaso Giarratano, Loretta D'Onofrio, Mario Airoldi, Chiara Saggia
Publikováno v:
Annals of Oncology. 31:S358
Autor:
Elena Geuna, Filippo Montemurro, Andrea Abbona, Ornella Garrone, Nicola Crosetto, Matteo Paccagnella, Massimo Di Maio, Cristiana Lo Nigro, Paola Vanella, Marco Merlano, Claudia De Angelis, Antonella Falletta, Anna Maria Vandone, Andrea Michelotti
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
ESMO Open
ESMO Open
Background Anticancer drugs can interact with the tumour microenvironment and their effects could be exploited to favour anticancer immune response. Eribulin contributes to tumour vasculature remodelling and transforming growth factor β (TGF-β) mod
Autor:
Luca Clivio, Luigi Cavanna, Giovanni Scognamiglio, Rosalba Rossello, Maria Rosaria Valerio, Marina Elena Cazzaniga, Graziella Pinotti, Maria Concetta Cursano, Virginia Casadei, Silvana Saracchini, Vittorio Gebbia, Salvatore Russo, Katia Cagossi, Benedetta Pellegrino, Salvatore Ortu, Enrico De Conciliis, Anna Maria Vandone, D. Toniolo, Elisabetta Melegari, Lucia Stocchi
e12552 Background: mCHT is the minimum biologically effective dose of a chemotherapeutic agent, given at regular dosing regimen with no prolonged drug free interval, that leads to anti-tumor activity. Old regimens included Cyclophosphamide-Methotrexa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199c8437fbbc4a35c4baf30e46636c1a
http://hdl.handle.net/10447/359925
http://hdl.handle.net/10447/359925